Hematologic Malignancy

A multimodal phone app proved feasible for addressing sexual dysfunction among hematopoietic stem cell transplant survivors, according to results presented at Tandem Meeting | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR.

Liquid biopsy could provide enhanced information about chimeric antigen receptor T-cell therapy compared with normally used DNA, RNA and protein assays, according to findings published in Journal for ImmunoTherapy of Cancer.

Steven A. Rosenberg, MD, PhD, FAACR, will be awarded the 2024 American Association for Cancer Research Award for Lifetime Achievement in Cancer Research during the AACR Annual Meeting in San Diego.

Monoclonal gammopathy of undetermined significance, a common precursor to multiple myeloma, developed significantly more in individuals with obesity, according to a study published in Blood Advances.

Patients with Merkel cell carcinoma have an increased risk for developing subsequent primary solid tumors and hematologic malignancies, according to data published in JAMA Dermatology.

Low levels of lymphocytes in the blood could indicate an increased risk for death, according to a study published in CMAJ.

Several factors contributed to inequities of outcomes among people with hematologic malignancies in the United States, according to findings presented at Society of Hematologic Oncology Annual Meeting.

The FDA approved omidubicel-onlv, a donor cord blood-based cell therapy, to accelerate neutrophil recovery and reduce the risk for infection among patients with hematologic malignancies undergoing stem cell transplantation.

For children with hematologic malignancies, a fever may indicate a deadly bloodstream infection and should be addressed as soon as possible.